Abbott Laboratories (ABT) is now holding trials to try and expand its rapid Covid-19 test to people who show no symptoms of the virus, ABT’s CEO Robert Ford has revealed to CNBC.“We are working on developing data for asymptomatic claims, so we are running our clinical trial, and we’ll eventually have data to be able to support that,” Ford told CNBC.“In the meantime, we see it being able to be deployed, because it doesn’t requirement an instrument … through the federal government, through the state governments, through schools, through employers, or even through retail clinics,” the CEO continued. “We think …read more
Source:: Yahoo Finance
